• Je něco špatně v tomto záznamu ?

Natriuretic peptides in addition to Zwolle score to enhance safe and early discharge after acute myocardial infarction: A prospective observational cohort study

E. Ganovska, M. Arrigo, K. Helanova, S. Littnerova, M. Sadoune, P. Kubena, M. Pavlusova, J. Jarkovsky, J. Gottwaldova, P. Kala, M. Dastych, S. Ishihara, LN. Van Aelst, A. Cohen-Solal, E. Gayat, J. Spinar, J. Parenica, A. Mebazaa, . ,

. 2016 ; 215 (-) : 527-31. [pub] 20160421

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc17031754

BACKGROUND: The Zwolle score is recommended to identify low-risk patients eligible for early hospital discharge after ST-elevation myocardial infarction (STEMI), but since only one third of STEMI has low Zwolle score, hospital discharge is frequently delayed. B-type natriuretic peptide (BNP) also provides prognostic information after STEMI. The aim of the study was to test the hypothesis that patients with high Zwolle score associated with low BNP share similar outcomes than those with low Zwolle score. METHODS AND RESULTS: The study population consisted of 1032 consecutive STEMI patients in whom BNP was measured 24h after chest pain onset. The area under the curve of Zwolle score and plasma BNP for 30-day mortality were 0.82 and 0.87, p=0.39. A BNP threshold of 200pg/ml had sensitivity of 100% and specificity of 34% for predicting 30-day mortality. Patients with high Zwolle score and BNP≤200pg/ml (n=183) had similar mortality and hospital stay to those with low Zwolle score (0% vs. 0.5% and 5 vs. 5days, both p=1.0). By contrast, patients with high Zwolle score and BNP>200pg/ml had the highest mortality (6.7%) and the longest hospital stay (6days), both p<0.01. CONCLUSION: STEMI patients with high Zwolle score but low BNP share similar outcomes with those with low Zwolle score and should be eligible for early discharge. Hence, using the rule of "low-Zwolle or low-BNP" might increase the number of STEMI patients that might be eligible for early discharge.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031754
003      
CZ-PrNML
005      
20171025123917.0
007      
ta
008      
171025s2016 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijcard.2016.04.148 $2 doi
035    __
$a (PubMed)27155548
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Ganovska, Eva $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Medical Faculty, Masaryk University, Brno, Czech Republic. Electronic address: evaganovska@gmail.com.
245    10
$a Natriuretic peptides in addition to Zwolle score to enhance safe and early discharge after acute myocardial infarction: A prospective observational cohort study / $c E. Ganovska, M. Arrigo, K. Helanova, S. Littnerova, M. Sadoune, P. Kubena, M. Pavlusova, J. Jarkovsky, J. Gottwaldova, P. Kala, M. Dastych, S. Ishihara, LN. Van Aelst, A. Cohen-Solal, E. Gayat, J. Spinar, J. Parenica, A. Mebazaa, . ,
520    9_
$a BACKGROUND: The Zwolle score is recommended to identify low-risk patients eligible for early hospital discharge after ST-elevation myocardial infarction (STEMI), but since only one third of STEMI has low Zwolle score, hospital discharge is frequently delayed. B-type natriuretic peptide (BNP) also provides prognostic information after STEMI. The aim of the study was to test the hypothesis that patients with high Zwolle score associated with low BNP share similar outcomes than those with low Zwolle score. METHODS AND RESULTS: The study population consisted of 1032 consecutive STEMI patients in whom BNP was measured 24h after chest pain onset. The area under the curve of Zwolle score and plasma BNP for 30-day mortality were 0.82 and 0.87, p=0.39. A BNP threshold of 200pg/ml had sensitivity of 100% and specificity of 34% for predicting 30-day mortality. Patients with high Zwolle score and BNP≤200pg/ml (n=183) had similar mortality and hospital stay to those with low Zwolle score (0% vs. 0.5% and 5 vs. 5days, both p=1.0). By contrast, patients with high Zwolle score and BNP>200pg/ml had the highest mortality (6.7%) and the longest hospital stay (6days), both p<0.01. CONCLUSION: STEMI patients with high Zwolle score but low BNP share similar outcomes with those with low Zwolle score and should be eligible for early discharge. Hence, using the rule of "low-Zwolle or low-BNP" might increase the number of STEMI patients that might be eligible for early discharge.
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a délka pobytu $7 D007902
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a natriuretický peptid typu B $x krev $7 D020097
650    _2
$a prognóza $7 D011379
650    _2
$a prospektivní studie $7 D011446
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a infarkt myokardu s elevacemi ST úseků $x krev $x mortalita $x terapie $7 D000072657
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a stupeň závažnosti nemoci $7 D012720
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Arrigo, Mattia $u INSERM UMR-S 942, Paris, France; Department of Anesthesiology and Critical Care Medicine, APHP, Saint Louis Lariboisière University Hospitals, Paris, France; Department of Cardiology, APHP, Lariboisière University Hospital, Paris, France; Division of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland. Electronic address: mattia.arrigo@usz.ch. $7 gn_A_00008881
700    1_
$a Helanova, Katerina $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Medical Faculty, Masaryk University, Brno, Czech Republic. Electronic address: trekar@seznam.cz.
700    1_
$a Littnerova, Simona $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic. Electronic address: littnerova@iba.muni.cz.
700    1_
$a Sadoune, Malha $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic. Electronic address: malha.sadoune@inserm.fr.
700    1_
$a Kubena, Petr $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Medical Faculty, Masaryk University, Brno, Czech Republic. Electronic address: petrkubena@seznam.cz.
700    1_
$a Pavlusova, Marie $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Medical Faculty, Masaryk University, Brno, Czech Republic. Electronic address: mpavlusova@seznam.cz.
700    1_
$a Jarkovsky, Jiri $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic. Electronic address: jarkovsky@iba.muni.cz.
700    1_
$a Gottwaldova, Jana $u Department of Biochemistry, University Hospital Brno, Brno, Czech Republic; Department of Laboratory Methods, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Electronic address: jgottwaldova@fnbrno.cz.
700    1_
$a Kala, Petr $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Medical Faculty, Masaryk University, Brno, Czech Republic. Electronic address: pkala@fnbrno.cz.
700    1_
$a Dastych, Milan $u Department of Biochemistry, University Hospital Brno, Brno, Czech Republic; Department of Laboratory Methods, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Electronic address: mdast@fnbrno.cz.
700    1_
$a Ishihara, Shiro $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic. Electronic address: ishiharashiro@hotmail.com.
700    1_
$a Van Aelst, Lucas N L $u INSERM UMR-S 942, Paris, France; Department of Cardiology, APHP, Lariboisière University Hospital, Paris, France; KU Leuven, Department of Cardiovascular Sciences, Leuven, Belgium. Electronic address: lucas.vanaelst@med.kuleuven.be.
700    1_
$a Cohen-Solal, Alain $u INSERM UMR-S 942, Paris, France; Department of Cardiology, APHP, Lariboisière University Hospital, Paris, France; Université Paris Diderot, PRES Sorbonne Paris Cité, France. Electronic address: alain.cohen-solal@aphp.fr.
700    1_
$a Gayat, Etienne $u INSERM UMR-S 942, Paris, France; Department of Anesthesiology and Critical Care Medicine, APHP, Saint Louis Lariboisière University Hospitals, Paris, France; Université Paris Diderot, PRES Sorbonne Paris Cité, France. Electronic address: etienne.gayat@aphp.fr.
700    1_
$a Spinar, Jindrich $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Medical Faculty, Masaryk University, Brno, Czech Republic. Electronic address: jspinar@fnbrno.cz.
700    1_
$a Parenica, Jiri $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Medical Faculty, Masaryk University, Brno, Czech Republic. Electronic address: jiri.parenica@atlas.cz.
700    1_
$a Mebazaa, Alexandre $u INSERM UMR-S 942, Paris, France; Department of Anesthesiology and Critical Care Medicine, APHP, Saint Louis Lariboisière University Hospitals, Paris, France; Université Paris Diderot, PRES Sorbonne Paris Cité, France. Electronic address: alexandre.mebazaa@aphp.fr.
700    1_
$a ,
773    0_
$w MED00002299 $t International journal of cardiology $x 1874-1754 $g Roč. 215, č. - (2016), s. 527-31
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27155548 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171025123959 $b ABA008
999    __
$a ok $b bmc $g 1255347 $s 992781
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 215 $c - $d 527-31 $e 20160421 $i 1874-1754 $m International journal of cardiology $n Int J Cardiol $x MED00002299
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Možnosti archivace